Swiss National Bank
NGNE icon

Swiss National Bank’s Neurogene NGNE Stock Holding History

Swiss National Bank’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,695
Closed -$534K – 2742
2021
Q3 		$534K Hold
3,695
– – ﹤0.01% 2577
2021
Q2 		$682K Buy
3,695
+390
+12% +$86.3K ﹤0.01% 2589
2021
Q1 		$814K Hold
3,305
– – ﹤0.01% 2391
2020
Q4 		$932K Buy
3,305
+305
+10% +$74.5K ﹤0.01% 2325
2020
Q3 		$720K Hold
3,000
– – ﹤0.01% 2257
2020
Q2 		$996K Buy
+3,000
New +$782K ﹤0.01% 2105

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Swiss National Bank's NGNE Position: Q4 2021 in Review

Swiss National Bank sold out of Neurogene (NGNE) in Q4 2021, closing a stake of 3,695 shares — an estimated $534K sold.

Swiss National Bank first reported a position in NGNE in Q2 2020 and held it in 6 quarters. The position peaked at $996K in Q2 2020. 80 funds tracked by Wall St. Rank hold NGNE as of Q4 2021.

  • Swiss National Bank reported no remaining Neurogene position as of Q4 2021 after selling out during the quarter.
  • Swiss National Bank sold 3,695 Neurogene shares in Q4 2021, an estimated $534K.
  • Swiss National Bank first reported a position in Neurogene in Q2 2020 and held it in 6 quarters.
  • Swiss National Bank's Neurogene position peaked at $996K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Neurogene as of Q4 2021.

Based on Swiss National Bank's 13F filing for Q4 2021, filed 8 Feb 2022.